John Alimamy Kabba
-
- Antibiotic Use and Resistance 10
- Neurology top 5%
- Neurological Disease Mechanisms and Treatments 2
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 4
-
- Antibiotic Resistance in Bacteria 3
-
- Global Maternal and Child Health 5
-
- Pneumonia and Respiratory Infections 4
-
- Patient Satisfaction in Healthcare 3
-
- School Health and Nursing Education 2
John Alimamy Kabba
25 papers receiving 494 citations
Peers
Comparison fields: 5 of 101
- Applied Microbiology and Biotechnology 104
- Neurology 143
- Geriatrics and Gerontology 48
- Biological Psychiatry 23
- Molecular Medicine 34
Countries citing papers authored by John Alimamy Kabba
This map shows the geographic impact of John Alimamy Kabba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Alimamy Kabba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Alimamy Kabba more than expected).
Fields of papers citing papers by John Alimamy Kabba
This network shows the impact of papers produced by John Alimamy Kabba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Alimamy Kabba. The network helps show where John Alimamy Kabba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Alimamy Kabba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 35 | |
| 11 | 2021 | 26 | |
| 12 | 2021 | 37 | |
| 13 | 2020 | 22 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 6 | |
| 17 | 2020 | 6 | |
| 18 | 2018 | 11 | |
| 19 | 2017 | 43 | |
| 20 | 2017 | 192 |
About John Alimamy Kabba
John Alimamy Kabba is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Molecular Medicine, having authored 26 papers that have together received 502 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (10 papers), Global Maternal and Child Health (5 papers), Pneumonia and Respiratory Infections (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Patient Satisfaction in Healthcare (3 papers), Antibiotic Resistance in Bacteria (3 papers), School Health and Nursing Education (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (104 citations), Neurology (143 citations) and Geriatrics and Gerontology (48 citations). John Alimamy Kabba has collaborated with scholars based in China, Australia and Sierra Leone. Frequent co-authors include Luyong Zhang, Wenchen Ruan, Yazhou Xu, Tao Pang, Yun Xiang, Juan M. Saavedra, Peter James, Yu Fang, Abdulai Jawo Bah and Jie Chang. Their work appears in journals such as Cellular and Molecular Neurobiology, International Journal of Environmental Research and Public Health, International Journal of Clinical Pharmacy, Infection and Drug Resistance and Health Policy and Planning.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.